...the company’s board of directors. Mr. Colangelo joins Promedior after a nearly 15-year pharmaceutical industry career at Eli Lilly and Company and most recently as Executive Vice President, Corporate Development and Operations at Oscient Pharmaceuticals. Mr....

...our corporate boardrooms who make decisions about continuing investments in Ireland,” Dr Farrell, who is managing director of Eli Lilly in Ireland, warned the Minister. The row comes in the context of last month’s report in the Irish Medical Journal that drug...

...Pfizer has showed restraint by, for instance, not jumping into a bidding war with Bristol-Myers Squibb (NYSE: BMY) and Eli Lilly (NYSE: LLY) over ImClone Systems. Based on Kindler's statements, I expect it'll do the same with other potential purchases. In...

...mega-mergers that created GlaxoSmithKline in 2001 and Pfizer’s $53bn takeover of Pharmacia in 2003. Such deals failed to deliver significant economies of scale or to reinvigorate innovation, although some analysts believe a new wave could help cut the rising...

...Delhi, Jan 5, (ANI/Business Wire India): Eli Lilly and Company, the International Diabetes Federation (IDF) and the International Society of Pediatric and Adolescent Diabetes (ISPAD) today announced the global launch of the Inspired by Diabetes Creative Expression...

...with big drug manufacturers in the past five years, as recently as Oct. 22. There are big corporations involved — Eli Lilly, Merck, Pfizer and Purdue Pharma — with brand-name drugs such as Celebrex, OxyContin and Vioxx, and settlements of millions of dollars,...

...1/2/2009 TOKYO and INDIANAPOLIS, December 31 /PRNewswire/ -- Daiichi Sankyo Company, Limited (TSE: 4568 - News) and Eli Lilly and Company (NYSE: LLY - News) today confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs...

...Metabolic Science and the Department of Radiology (T.C.S., D.J.L.), Addenbrooke's Hospital, Cambridge, United Kingdom; Eli Lilly, Lilly Corporate Center, Indianapolis (J.W.M., J.H.S., G.S.C., J.P.M.); and Biotrial, Rennes, France (B.A.). This article (10.1056/NEJMoa0803085)...

...ACS patients are managed with PCI, which usually includes a stent placement. Daiichi Sankyo Company, Limited , and Eli Lilly and Company are co-developing prasugrel, an investigational oral antiplatelet agent discovered by Daiichi Sankyo and its Japanese research...

...TOKYO and INDIANAPOLIS, Dec. 31 /PRNewswire-FirstCall/ -- Daiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY) today confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee...